Several antagonists for this receptor have been developed and are widely used in research, with the best-known agents being the selective CRF-1 antagonist antalarmin and a newer drug pexacerfont, although several other ligands for this receptor are used in research, such as LWH-234, CP-154,526, NBI-27914 and R-121,919.
Producers Releasing Corporation | hormone | receptor antagonist | growth hormone | Luteinizing hormone | Growth hormone | Thyroid-stimulating hormone | Sex hormone-binding globulin | Receptor antagonist | Parathyroid hormone | Maximum the Hormone | luteinizing hormone | Hormone-sensitive lipase | Growth Hormone (treatment) | Growth hormone deficiency | Endothelin receptor antagonist | Competitive antagonist | Angiotensin II receptor antagonist |